Drdgold annual ebitda
2018
2020
2021
2022
2023
2024
2025
Drdgold's calculated EBITDA was R3.38B for fiscal 2025.
View full Drdgold company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | R3.38B | R1.49B | +79.29% |
| 2024 | 2024-06-30 | R1.88B | R242.6M | +14.79% |
| 2023 | 2023-06-30 | R1.64B | R65.6M | +4.17% |
| 2022 | 2022-06-30 | R1.57B | −R494.7M | −23.91% |
| 2021 | 2021-06-30 | R2.07B | R860.7M | +71.21% |
| 2020 | 2020-06-30 | R1.21B | R988.7M | +449.41% |
| 2018 | 2018-06-30 | R220.0M | — | — |
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
Over the last five reported fiscal years, Drdgold's ebitda increased from R1.21B to R3.38B, a change of R2.17B.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Drdgold filings at SEC.gov ↗